Cover Image

PRESERFL MicroShunt as a treatment option for highly increased intraocular pressure in primary open angle glaucoma and pseudoexfoliation glaucoma

The Preserflo-MicroShunt (PF) is an established device for treating glaucoma, effectively reducing intraocular pressure (IOP) with a good safety record. However, its efficacy in eyes with significantly elevated preoperative IOP levels is not well-documented due to exclusion from many clinical studie...

Full description

Saved in:
Bibliographic Details
Main Authors: Theilig, Theresa (Author) , Papadimitriou, Menelaos (Author) , Meller, Daniel (Author) , Hasan, Somar (Author)
Format: Article (Journal)
Language:English
Published: August 2025
In: Eye
Year: 2025, Volume: 39, Issue: 11, Pages: 2253-2259
ISSN:1476-5454
DOI:10.1038/s41433-025-03843-w
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41433-025-03843-w
Verlag, kostenfrei, Volltext: http://www.nature.com/articles/s41433-025-03843-w
Get full text
Author Notes:Theresa Theilig, Menelaos Papadimitriou, Daniel Meller and Somar M. Hasan
Description
Summary:The Preserflo-MicroShunt (PF) is an established device for treating glaucoma, effectively reducing intraocular pressure (IOP) with a good safety record. However, its efficacy in eyes with significantly elevated preoperative IOP levels is not well-documented due to exclusion from many clinical studies. This study aims to evaluate PF outcomes in eyes with highly increased IOP and compare them with those having moderately increased levels.
Item Description:Online veröffentlicht: 19. Mai 2025
Gesehen am 21.08.2025
Physical Description:Online Resource
ISSN:1476-5454
DOI:10.1038/s41433-025-03843-w

Similar Items